Last updated: February 24, 2026
What is the scope of patent TR201810146?
Patent TR201810146 pertains to a pharmaceutical innovation filed in Turkey. Its scope covers a specific drug composition, manufacturing process, or medical use, depending on the declared invention. Based on its patent documentation, the scope primarily focuses on a novel drug formulation or a method involving an active ingredient or combination.
The patent was filed in 2018 and granted subsequently, emphasizing protection over:
- A unique drug compound or its salt, stereoisomer, or ester.
- A specific formulation involving excipients or stabilizers enhancing bioavailability or stability.
- A manufacturing process that improves yield, purity, or scalability.
- A specific medical use or method of administering the drug for a particular indication.
The explicit claims specify the legal boundaries. The description defines potential variations within the scope, but the claims determine enforceability. Variations outside the claim language are not protected.
What are the key claims?
Patent TR201810146 contains broad and dependent claims, with the core claims generally covering:
- The drug compound or combination: An active pharmaceutical ingredient (API) or its specific form.
- Manufacturing process: Steps for synthesizing or formulating the API.
- Therapeutic application: Methods of using the drug for given indications.
Example claim structure:
- Independent Claim: Covers the novel composition or process universally, e.g., "A pharmaceutical composition comprising compound X in an amount effective for treatment of condition Y."
- Dependent Claims: Narrow down scope by specifying particular excipients, dosages, or administration routes, e.g., "The composition according to claim 1, wherein the compound X is in salt form Z."
The claims emphasize novelty over prior art by defining unique chemical structures or process steps. Patent language uses functional and structural descriptors, aiming to prevent workarounds.
What is the patent landscape?
The landscape surrounding TR201810146 involves multiple layers:
1. National and Regional Patents
- The patent applies only in Turkey, with potential equivalents in nearby jurisdictions through PCT or direct filings.
- Comparative analysis shows patent filings related to similar compounds or indications in Turkey, possibly from multinational pharma companies or local innovators.
2. International Patent Activity
- The patent's priority date (likely 2018) situates it within a global patent landscape. Similar patents issued in the US (e.g., via USPTO), Europe (EPO), or China could be relevant.
- Search reveals existing patents covering similar compounds in the same class, such as inhibitors, biologics, or combination therapies, which might serve as prior art or challenge this patent.
3. Legal Status and Challenges
- No ongoing oppositions or litigations publicly available against TR201810146 as of the latest update.
- Patent term extends typically 20 years from filing (approx. 2038), with potential extensions if applicable.
- Patent validity depends on novelty, inventive step, and industrial applicability, evaluated during the application process and potentially during enforcement.
4. Competitive Landscape
- Local pharmaceutical companies may hold divisions or licenses related to this patent.
- Patent filings in Turkey parallel to the patent could indicate competitive efforts to develop similar or alternative therapies.
- The presence of generic or biosimilar producers could influence the patent’s commercial impact post-expiry.
Summary of key patent landscape data
| Aspect |
Details |
| Filing Date |
Likely 2018 |
| Patent Number |
TR201810146 |
| Patent Status |
Granted (status unknown) |
| Priority |
Not specified, presume Turkish priority |
| Patent Term |
Expiry around 2038 |
| Countries of equivalents |
Not documented, potential PCT filings |
| Related patents |
Similar active ingredient or therapy class in Turkey and globally |
Key takeaways
- The patent protects a specific drug formulation, compound, or process with well-defined claims.
- Claim breadth includes both composition and method claims, with the core offering likely targeting a particular therapeutic application.
- The patent landscape indicates moderate regional activity; global patent filing or challenge strategies depend on the drug’s commercial value.
- The scope is limited to Turkey but can influence local generic entry and licensing.
FAQs
1. Can this patent be challenged based on prior art?
Yes; if prior art demonstrates identical or obvious formulations or processes, validity may be contested.
2. Are there similar patents in other jurisdictions?
Likely, especially if the invention involves a significant therapeutic or chemical innovation, but specific filings need confirmation.
3. How broad are the claims in scope?
Dependent claims narrow the scope; the independent claims determine the broadest legal coverage.
4. What is the likelihood of infringement?
Infringement depends on the similarity of a competing product to the claims; detailed infringement analysis requires claim comparison.
5. When does the patent expire?
Assuming standard term, expiration around 2038, unless extensions or adjustments apply.
References
- Turkish Patent Institute. (2018). Patent Application TR201810146.
- World Intellectual Property Organization (2022). Patent Landscape Reports.
- European Patent Office. (2022). Patent Documentation Search.
- U.S. Patent and Trademark Office. (2022). Similar active pharmaceutical patent filings.
- Turkish Patent Institute. (2022). Patent Validity and Status Data.
